Cargando…

COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey

Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study’s objectives were to assess COVID-19 VH before and after vaccines' availability and to analyze the associations between COVID-19 VH and participants’ characteristics. A national...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankenthal, Dvora, Zatlawi, Miri, Karni-Efrati, Ziv, Keinan-Boker, Lital, Luxenburg, Osnat, Bromberg, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472961/
https://www.ncbi.nlm.nih.gov/pubmed/36137905
http://dx.doi.org/10.1016/j.vaccine.2022.08.070
_version_ 1784789403074297856
author Frankenthal, Dvora
Zatlawi, Miri
Karni-Efrati, Ziv
Keinan-Boker, Lital
Luxenburg, Osnat
Bromberg, Michal
author_facet Frankenthal, Dvora
Zatlawi, Miri
Karni-Efrati, Ziv
Keinan-Boker, Lital
Luxenburg, Osnat
Bromberg, Michal
author_sort Frankenthal, Dvora
collection PubMed
description Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study’s objectives were to assess COVID-19 VH before and after vaccines' availability and to analyze the associations between COVID-19 VH and participants’ characteristics. A national cross-sectional telephone interview survey among Israeli adults aged 21 and older was conducted from September 2020 through May 2021. Attitudes towards COVID-19 vaccines were assessed pre/post vaccines' availability. Multivariate logistic regression analyses were used to identify associations between demographic and health-related characteristics and COVID-19 VH. Most study participants (72.0 % of 2,998) were willing to be vaccinated against COVID-19 across the survey period. The COVID-19 VH declined significantly from 45.6 % pre-vaccine availability to 16.3 % post-vaccine availability (P < 0.001). The multivariable analysis demonstrated that post-vaccine availability, COVID-19 VH was associated with younger age, Arab ethnicity, higher level of religiosity, lower education, past diagnosis of COVID-19, and influenza VH. The main reasons for VH after the vaccine availability included insufficient data on the vaccine (37.4 %) and fear of the vaccine's side effects (33.8 %). Despite the significant decrease in COVID-19 VH following vaccine availability, 16.3% of the population still refuses to get vaccinated. As Israel may face additional waves of the COVID-19 pandemic and booster vaccinations, multimedia vaccine promotions targeting the above-mentioned hesitant populations and their reasons for VH are urgently needed.
format Online
Article
Text
id pubmed-9472961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94729612022-09-15 COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey Frankenthal, Dvora Zatlawi, Miri Karni-Efrati, Ziv Keinan-Boker, Lital Luxenburg, Osnat Bromberg, Michal Vaccine Article Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study’s objectives were to assess COVID-19 VH before and after vaccines' availability and to analyze the associations between COVID-19 VH and participants’ characteristics. A national cross-sectional telephone interview survey among Israeli adults aged 21 and older was conducted from September 2020 through May 2021. Attitudes towards COVID-19 vaccines were assessed pre/post vaccines' availability. Multivariate logistic regression analyses were used to identify associations between demographic and health-related characteristics and COVID-19 VH. Most study participants (72.0 % of 2,998) were willing to be vaccinated against COVID-19 across the survey period. The COVID-19 VH declined significantly from 45.6 % pre-vaccine availability to 16.3 % post-vaccine availability (P < 0.001). The multivariable analysis demonstrated that post-vaccine availability, COVID-19 VH was associated with younger age, Arab ethnicity, higher level of religiosity, lower education, past diagnosis of COVID-19, and influenza VH. The main reasons for VH after the vaccine availability included insufficient data on the vaccine (37.4 %) and fear of the vaccine's side effects (33.8 %). Despite the significant decrease in COVID-19 VH following vaccine availability, 16.3% of the population still refuses to get vaccinated. As Israel may face additional waves of the COVID-19 pandemic and booster vaccinations, multimedia vaccine promotions targeting the above-mentioned hesitant populations and their reasons for VH are urgently needed. Elsevier Ltd. 2022-10-12 2022-09-14 /pmc/articles/PMC9472961/ /pubmed/36137905 http://dx.doi.org/10.1016/j.vaccine.2022.08.070 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Frankenthal, Dvora
Zatlawi, Miri
Karni-Efrati, Ziv
Keinan-Boker, Lital
Luxenburg, Osnat
Bromberg, Michal
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
title COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
title_full COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
title_fullStr COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
title_full_unstemmed COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
title_short COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
title_sort covid-19 vaccine hesitancy among israeli adults before and after vaccines’ availability: a cross-sectional national survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472961/
https://www.ncbi.nlm.nih.gov/pubmed/36137905
http://dx.doi.org/10.1016/j.vaccine.2022.08.070
work_keys_str_mv AT frankenthaldvora covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey
AT zatlawimiri covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey
AT karniefratiziv covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey
AT keinanbokerlital covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey
AT luxenburgosnat covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey
AT brombergmichal covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey